Lv22
150 积分 2025-03-20 加入
Landscape of anti-IL-23 therapy in inflammatory bowel disease: recent advances
21小时前
待确认
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
7天前
已完结
Immunotherapy
13天前
已关闭
Immunotherapy
13天前
已关闭
Immunotherapy
13天前
已关闭
Engineering IL-2 for immunotherapy of autoimmunity and cancer
13天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
21天前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
22天前
已完结
Advances in the Medical Treatment of Thyroid Eye Disease: Current and Emerging Therapies
27天前
已关闭
Lifileucel: First Approval
29天前
已完结
皖公网安备34019202002308
